| المؤلفون: |
Swords RT; Leukemia Program, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, FL, United States. Electronic address: rswords@med.miami.edu., Greenberg PL; Stanford Cancer Institute, Stanford, CA, United States., Wei AH; The Alfred Hospital and Monash University, Melbourne, Australia., Durrant S; The Royal Brisbane and Women's Hospital, Brisbane, Australia., Advani AS; Cleveland Clinic, Cleveland, OH, United States., Hertzberg MS; Westmead Hospital, Westmead, Australia., Lewis ID; The Royal Adelaide Hospital, Adelaide, Australia., Rivera G; Stanford Cancer Institute, Stanford, CA, United States., Gratzinger D; Stanford Cancer Institute, Stanford, CA, United States., Fan AC; Stanford Cancer Institute, Stanford, CA, United States., Felsher DW; Stanford Cancer Institute, Stanford, CA, United States., Cortes JE; The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Watts JM; Leukemia Program, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, FL, United States., Yarranton GT; KaloBios Pharmaceuticals, Inc., South San Francisco, CA, United States., Walling JM; KaloBios Pharmaceuticals, Inc., South San Francisco, CA, United States., Lancet JE; H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, United States. |
Full Text via ClinicalKey 
Full Text Finder